144 related articles for article (PubMed ID: 33334663)
1. Combined application of MRS and DWI can effectively predict cell proliferation and assess the grade of glioma: A prospective study.
Hu X; Xue M; Sun S; Zou Y; Li J; Wang X; Liu X; Ma H
J Clin Neurosci; 2021 Jan; 83():56-63. PubMed ID: 33334663
[TBL] [Abstract][Full Text] [Related]
2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
4. Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.
Lotumolo A; Caivano R; Rabasco P; Iannelli G; Villonio A; D' Antuono F; Gioioso M; Zandolino A; Macarini L; Guglielmi G; Cammarota A
Eur J Radiol; 2015 Dec; 84(12):2597-604. PubMed ID: 26391231
[TBL] [Abstract][Full Text] [Related]
5. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI in differentiating solitary brain metastasis from high-grade glioma: diagnostic value of the combined use of diffusion-weighted imaging, dynamic susceptibility contrast imaging, and magnetic resonance spectroscopy parameters.
Aslan K; Gunbey HP; Tomak L; Incesu L
Neurol Neurochir Pol; 2019; 53(3):227-237. PubMed ID: 31180131
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
8. Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis.
Li H; Duan Y; Liu N; Dong J; Liang Y; Ju R
Int J Clin Pract; 2022; 2022():1629570. PubMed ID: 36380750
[TBL] [Abstract][Full Text] [Related]
9. Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis.
Dou W; Zhang M; Zhang X; Li Y; Chen H; Li S; Lu M; Dai J; Constans JM
PLoS One; 2015; 10(9):e0137850. PubMed ID: 26367871
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
[TBL] [Abstract][Full Text] [Related]
11. [The clinical application of hydrogen magnetic resonance spectroscopy combining with diffusion weight imaging in brain gliomas grading].
Xu S; Ouyang Y; Luo T; Zeng Y; Zhou X; Xiao J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Jun; 28(3):470-4. PubMed ID: 21774204
[TBL] [Abstract][Full Text] [Related]
12. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy.
Liu ZL; Zhou Q; Zeng QS; Li CF; Zhang K
J Int Med Res; 2012; 40(1):76-84. PubMed ID: 22429347
[TBL] [Abstract][Full Text] [Related]
14. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
[TBL] [Abstract][Full Text] [Related]
15. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
16. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
[TBL] [Abstract][Full Text] [Related]
18. Advanced MR imaging and
Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
[TBL] [Abstract][Full Text] [Related]
19. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
20. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
